Join your colleagues in a live Webinar event...

A FREE Continuing Education Program for Nurses and Pharmacists

Glycemic Control in the ICU: New Technology for Better Care

Program Schedule (3 dates to choose from):

CLICK HERE to register for the August 17 webinar

CLICK HERE to register for the September 15 webinar

CLICK HERE to register for the October 19 webinar

CLICK HERE to download the program flyer

Program Description:
Blood glucose management is a critical factor to optimize patient care outcomes in the ICU. Existing protocols for infusing IV insulin can result in poor or inconsistent glycemic control, as evidenced by cases of hypoglycemia and in miscalculations of insulin dosage. This program will demonstrate why advanced technology for managing IV insulin drips is often warranted, and how implementation can potentially impact patient safety and outcomes.
 
Learning Objectives:
Upon completion of this activity, nurses and pharmacists will be able to:

• Restate the rationale for maintaining target blood glucose levels in ICU patients and the outcomes achievable with paper protocols versus computer-based programs
• Discuss challenges in transitioning from IV insulin to subcutaneous regimens

Faculty:

Dawn Greene, RN, CCRN, CSC
Nurse Educator - Cardiovascular Intensive Care and Recovery
Mission Hospitals
Asheville, North Carolina

Joe Rafferty, PharmD
Clinical Pharmacy Specialist
Cardiology
Mission Hospitals
Asheville, North Carolina
 
Funding:
This program is supported by an educational grant from Hospira, Inc.

 
Disclosure:
It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Faculty conflict of interest disclosures will be announced at the beginning of the CE activity.
 
Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.
 
Accreditation:
Pharmacists:
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-10-028-L01-P has been assigned to this live knowledge-based webinar (initial release date 08-17-10). This program is approved for 0.5 contact hours (0.05 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online at www.ProCE.com upon successful completion of the program evaluation. Participants must complete a program evaluation to receive pharmacy CE credit. No partial credit will be given.
 
Nurses:
CE is provided for this program through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, WSNA CEARP Provider number PA-5/Feb/11, is an approved provider of continuing education by the Washington State Nurses Association, an accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation. California Board of Registered Nursing Provider #12300. This activity provides 0.5 contact hours of nurse CE credit.